• Cisplatin in Cancer Research: New Frontiers in DNA Crossl...

  2026-03-27

  Explore how Cisplatin, a leading chemotherapeutic compound, advances cancer research through DNA crosslinking, apoptosis pathway modulation, and novel insights into chemoresistance. This article uniquely integrates molecular mechanisms and translational strategies to empower next-generation oncology studies.

• Harnessing 2'3'-cGAMP (sodium salt) to Decipher and Direc...

  2026-03-27

  This thought-leadership article explores the strategic integration of 2'3'-cGAMP (sodium salt) in translational research focused on the cGAS-STING signaling axis. By connecting mechanistic advances—such as the role of cytoplasmic chromatin fragments (CCFs) and SASP in cancer progression—with hands-on guidance for experimental design, this piece provides actionable insight for researchers targeting innate immunity, cancer immunotherapy, and antiviral responses. Drawing on recent literature, including the latest findings in small cell lung cancer, and synthesizing scenario-based best practices, we illustrate the unmatched value of APExBIO’s 2'3'-cGAMP (sodium salt) as a research-grade STING agonist for the next wave of immunomodulatory discovery.

• 2'3'-cGAMP (sodium salt): Advanced STING Agonist for Inna...

  2026-03-26

  2'3'-cGAMP (sodium salt) from APExBIO empowers researchers to dissect the cGAS-STING signaling pathway with high specificity and reproducibility, enabling breakthroughs in immunotherapy, antiviral research, and innate immunity studies. Its superior water solubility and robust activation of type I interferon responses make it the preferred tool for both fundamental discovery and translational applications.

• ABT-888 (Veliparib): Potent PARP1/2 Inhibitor for Chemoth...

  2026-03-26

  ABT-888 (Veliparib) is a highly selective poly (ADP-ribose) polymerase (PARP) inhibitor used extensively in preclinical cancer research. As a chemo- and radiosensitizer, it impairs DNA repair pathways, enabling enhanced cytotoxicity in tumor models with DNA repair deficiencies.

• ABT-888: Potent PARP Inhibitor for Chemotherapy Sensitiza...

  2026-03-25

  Unlock advanced DNA repair inhibition and chemotherapy sensitization with ABT-888 (Veliparib), a potent PARP1 and PARP2 inhibitor trusted by APExBIO. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights for optimizing workflows in colorectal, MSI, and tumor xenograft research models.

• 2'3'-cGAMP (Sodium Salt): Advanced Applications in Immune...

  2026-03-25

  Explore how 2'3'-cGAMP (sodium salt) enables precision modulation of the cGAS-STING signaling pathway for immunotherapy research, autoimmune disease modeling, and antiviral studies. Discover unique mechanistic insights and translational applications that set this research-grade STING agonist apart.

• ABT-888 (Veliparib): Potent PARP1/2 Inhibitor for Cancer ...

  2026-03-24

  ABT-888 (Veliparib) is a highly potent and selective poly (ADP-ribose) polymerase (PARP) inhibitor, widely used in preclinical cancer research for DNA repair inhibition and chemotherapy sensitization. Its validated synergy with DNA-damaging agents and robust benchmarks in MSI and colon cancer models make it a cornerstone for translational oncology studies.

• Cisplatin in Cancer Research: Redefining Chemoresistance ...

  2026-03-24

  Explore how Cisplatin (CDDP), a DNA crosslinking agent for cancer research, reveals emerging mechanisms of chemoresistance and oxidative stress modulation. This in-depth article uniquely analyzes KEAP1/NRF2 signaling and its impact on apoptosis, setting a new benchmark for advanced chemotherapy resistance studies.

• Cisplatin (A8321): Atomic Benchmarks for Chemoresistance ...

  2026-03-23

  Cisplatin (CDDP) is a platinum-based chemotherapeutic compound renowned for its DNA crosslinking and apoptosis-inducing capabilities in cancer research. This article delivers atomic, verifiable facts on its molecular mechanism, resistance pathways, and validated workflows, establishing APExBIO’s Cisplatin as a gold-standard tool for benchmarking cell death and tumor inhibition.

• Cisplatin (SKU A8321): Scenario-Driven Solutions for Reli...

  2026-03-23

  This article addresses real-world laboratory challenges in cancer research using Cisplatin (SKU A8321), a gold-standard DNA crosslinking agent. Through scenario-driven Q&A, it delivers actionable strategies for protocol optimization, data interpretation, chemoresistance studies, and vendor selection. Researchers will find practical, evidence-based guidance to ensure reproducibility and superior experimental outcomes with APExBIO’s Cisplatin.

• 5-Methyl-CTP: Modified Cytidine Triphosphate for Enhanced...

  2026-03-22

  5-Methyl-CTP is a 5-methyl modified cytidine triphosphate utilized in in vitro transcription to enhance mRNA stability and translation efficiency. Incorporation of this nucleotide supports mRNA synthesis workflows by mimicking endogenous methylation, essential for advanced gene expression research and mRNA drug development.

• 5-Methyl-CTP: Modified Nucleotide for Enhanced mRNA Stabi...

  2026-03-21

  5-Methyl-CTP is a 5-methyl modified cytidine triphosphate used in in vitro transcription to improve mRNA stability and translation efficiency. As a key reagent for gene expression research and mRNA drug development, it mimics endogenous RNA methylation to protect synthetic mRNA from degradation. This article details its mechanism, applications, and evidence base.

• 2'3'-cGAMP (Sodium Salt): Unlocking REC8 and STING Synerg...

  2026-03-20

  Explore how 2'3'-cGAMP (sodium salt) enables breakthroughs in STING-mediated innate immune response by integrating REC8 signaling insights. This article reveals novel mechanisms, advanced applications in immuno-oncology and antiviral studies, and strategic guidance for leveraging this research-grade STING agonist.

• 5-Methyl-CTP (SKU B7967): Advancing Reliable mRNA Synthes...

  2026-03-20

  This scenario-driven resource empowers biomedical researchers and lab technicians to overcome common mRNA synthesis and assay reproducibility challenges by leveraging 5-Methyl-CTP (SKU B7967) as a reliable, high-purity modified nucleotide. Grounded in practical laboratory situations and supported by quantitative data, the article details how APExBIO’s 5-Methyl-CTP enhances mRNA stability, translation efficiency, and experimental consistency in gene expression and mRNA-based drug development workflows.

• Optimizing STING Assays with 2'3'-cGAMP (Sodium Salt): Pr...

  2026-03-19

  This article offers scenario-driven insights for biomedical researchers using 2'3'-cGAMP (sodium salt) (SKU B8362) in cell viability and immune signaling assays. Drawing on validated protocols and real-world laboratory challenges, it details how this high-affinity, water-soluble STING agonist from APExBIO ensures reproducibility, sensitivity, and robust type I interferon induction in innate immunity research.

14884 records 1/993 page Next 12345 下5页 Last page